Forekomsten af alvorlige hændelser i forbindelse med cerivastatin 0, 4 mg er sammenlignelige med atorvastatin, men lidt højere end for simvastatin og meget lavere end for lovastatin i ækvipotente doser.
The incidence of serious adverse events with cerivastatin 0.4mg is comparable with atorvastatin, but slightly higher than that seen with simvastatin and considerably less than that with lovastatin at equipotent doses.